- Home
- Products
Alunbrig (Brigatinib)
Alunbrig (Brigatinib)
- Medicine Name:Alunbrig
- Generic Name: Brigatinib
- Dosage Form & Strength: Tablets – 30 mg, 90 mg, 180 mg
- Manufactured By: Takeda Pharmaceutical Company Limited
Alunbrig is a tyrosine kinase inhibitor (TKI) indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), as confirmed by an FDA-approved diagnostic test.
Recommended Dosage:
- 90 mg orally once daily for the first 7 days
- Increase to 180 mg once daily thereafter, with or without food
- Swallow tablets whole; do not crush or split
- If a dose is missed or vomiting occurs, resume the regular dosing schedule without taking an additional dose
Pulmonary Adverse Reactions (ILD/Pneumonitis): Monitor for respiratory symptoms, especially in the first week. Discontinue if ILD is suspected.
Hypertension: Monitor blood pressure at baseline, after 2 weeks, and monthly thereafter.
Bradycardia: Monitor heart rate, especially if combined with other medications that lower heart rate.
Fetal Harm: May cause fetal harm. Use non-hormonal contraception during and after treatment (4 months for women, 3 months for men).
Documents Required to Import Alunbrig to India:
- Valid prescription from a qualified oncologist
- Patient’s diagnostic reports
- Government-issued photo ID
Order Confirmation:
- Orders are confirmed upon submission of complete documents and import permit (if required)
Availability in India & Internationally: Available via Global Rare Meds in Mumbai, Delhi, Hyderabad, Bangalore, Chennai, Pune, Kolkata, Ahmedabad, and other Indian cities. Also available for export to eligible countries through the Named Patient Program.
To Enquire or Order:
- 📞 Call / WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Alunbrig from FDA-approved and licensed suppliers in the USA, Canada, Europe, and Australia. All prescriptions are validated by registered pharmacists and dispatched from our secure fulfillment center in Ambernath, Thane District.
We ensure full legal compliance, product authenticity, and timely international delivery.
What is the generic name of Alunbrig®?
Brigatinib
Who manufactures Alunbrig®?
Takeda Pharmaceutical Company Limited
Is Alunbrig® FDA approved?
Yes. Approved by the FDA on April 28, 2017
What is Alunbrig® used for?
ALK-positive metastatic non-small cell lung cancer (NSCLC)
What dosage forms are available?
Tablets – 30 mg, 90 mg, and 180 mg
What are common side effects?
Diarrhea, fatigue, nausea, rash, cough, muscle pain, headache, hypertension, vomiting, difficulty breathing
What is the cost of Alunbrig® in India?
Prices vary. Contact us via WhatsApp (+91-99675 15602) or email (info@globalraremeds.com) for the latest pricing
How should Alunbrig® be stored?
Store at 20°C to 25°C (68°F to 77°F)
Can I buy Alunbrig® online from India?
Yes. Global Rare Meds enables legal and safe access through the Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
